Up­dat­ed: Amid mas­sive re­struc­tur­ing, Bio­gen looks to re­duce phys­i­cal pres­ence in Boston

Bio­gen is putting a siz­able chunk of of­fice and re­search space in Kendall Square and We­st­on, MA up for sub­lease, mark­ing an­oth­er big change as the biotech grap­ples with the af­ter­shock of a dis­as­trous and con­tro­ver­sial roll­out for its Alzheimer’s drug.

The sub­bleas­es are “part of Bio­gen’s over­all im­ple­men­ta­tion of the ‘Fu­ture of Work,’ which is al­low­ing us to op­ti­mize our foot­print and re­duce the amount of space we oc­cu­py, tak­ing in­to con­sid­er­a­tion new el­e­ments such as the hy­brid work mod­el,” Bio­gen spokesper­son Ash­leigh Koss wrote in a state­ment to End­points News, adding that the com­pa­ny has had sub­leas­es across sev­er­al build­ings for years.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER